We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Insulet Corporation (PODD) Com Stk USD0.001

Sell:$262.65 Buy:$262.80 Change: $0.93 (0.36%)
NASDAQ:0.16%
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$262.65
Buy:$262.80
Change: $0.93 (0.36%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$262.65
Buy:$262.80
Change: $0.93 (0.36%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Contact details

Address:
100 Nagog Park
ACTON
01720-3440
United States
Telephone:
+1 (978) 6007000
Website:
https://www.omnipod.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PODD
ISIN:
US45784P1012
Market cap:
$18.70 billion
Shares in issue:
70.14 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • James Hollingshead
    President, Chief Executive Officer, Director
  • Ana Chadwick
    Chief Financial Officer, Executive Vice President, Treasurer
  • Dan Manea
    Chief Human Resource Officer, Senior Vice President
  • Eric Benjamin
    Executive Vice President, Chief Product and Customer Experience Officer
  • Mark Field
    Senior Vice President, Chief Technology Officer
  • John Kapples
    Senior Vice President, General Counsel
  • Laetitia Cousin
    Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
  • Prem Singh
    Senior Vice President - Global Operations
  • Lauren Budden
    Chief Accounting Officer, Group Vice President, Controller

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.